Finerenone: Efficacy of a New Nonsteroidal Mineralocorticoid Receptor Antagonist in Treatment of Patients With Chronic Kidney Disease and Type 2 Diabetes.

Dey, Subo; Garg, Jasmine; Wang, Andy; Holzner, Eva; Frishman, William H; Aronow, Wilbert S

Dey, Subo; Garg, Jasmine; Wang, Andy; Holzner, Eva; Frishman, William H; Aronow, Wilbert S.

Affiliation

Dey S; From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Garg J; From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Wang A; From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Holzner E; Department of Family Medicine, SUNY Downstate, Brooklyn, NY.
Frishman WH; From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Aronow WS; From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.

Cardiol Rev ; 32(3): 285-288, 2024.

Article de En | MEDLINE | ID: mdl-36946916

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Insuffisance rénale chronique / Défaillance cardiaque / Naphtyridines Limites: Humans Langue: En Journal: Cardiol Rev Sujet du journal: ANGIOLOGIA / CARDIOLOGIA Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google